IP Library › Patent Application 12124262
Patent Application
App. No. 12/124,262

USE OF SAREDUTANT OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS IN THE TREATMENT OF MIXED ANXIETY-DEPRESSION DISORDERS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/124,262
Abstract

The present invention relates to the use of saredutant and of its pharmaceutically acceptable salts for the preparation of medicinal products that are useful in the treatment or prevention of mixed anxiety-depression disorders.

Claims (1)

1 . A method for the treatment of mixed anxiety-depression disorders which comprises administering to a patient in need of said treatment an effective amount of saredutant or a pharmaceutically acceptable salt thereof.